Travere Therapeutics SG&A Expense (Quarterly) Insights

Travere Therapeutics Inc (TVTX)

6.30 -0.29 (-4.40%) USD | NASDAQ | May 10, 16:00

6.30 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2010. Upgrade now.

Date	Value
March 31, 2024	64.22M
December 31, 2023	63.59M
September 30, 2023	67.80M
June 30, 2023	74.04M
March 31, 2023	65.95M
December 31, 2022	57.09M
September 30, 2022	52.42M
June 30, 2022	52.98M
March 31, 2022	46.79M
December 31, 2021	18.48M
September 30, 2021	36.06M
June 30, 2021	34.96M
March 31, 2021	36.78M
December 31, 2020	35.74M
September 30, 2020	31.95M
June 30, 2020	34.97M
March 31, 2020	33.14M
December 31, 2019	27.53M
September 30, 2019	29.78M
June 30, 2019	38.97M
March 31, 2019	32.67M
December 31, 2018	25.98M
September 30, 2018	26.11M
June 30, 2018	25.10M
March 31, 2018	26.47M

Date	Value
December 31, 2017	27.28M
September 30, 2017	24.85M
June 30, 2017	28.84M
March 31, 2017	23.12M
December 31, 2016	26.23M
September 30, 2016	28.68M
June 30, 2016	23.20M
March 31, 2016	19.12M
December 31, 2015	22.68M
September 30, 2015	22.31M
June 30, 2015	19.69M
March 31, 2015	14.86M
December 31, 2014	17.55M
September 30, 2014	17.37M
June 30, 2014	9.579M
March 31, 2014	15.15M
December 31, 2013	7.298M
September 30, 2013	3.755M
June 30, 2013	4.442M
March 31, 2013	1.727M
November 30, 2012	0.0032M
August 31, 2012	0.003M
May 31, 2012	0.003M
February 29, 2012	0.0038M
November 30, 2011	0.003M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

18.48M

Minimum

Dec 2021

74.04M

Maximum

Jun 2023

45.16M

Average

37.87M

Median

SG&A Expense (Quarterly) Benchmarks